Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. …
| Métrica | GELS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 30.3% | 57.4% | -27.1% |
| Operating Margin | -3317.7% | -34.4% | -3283.3% |
| Net Margin | -4011.9% | -32.5% | -3979.4% |
| FCF Margin | -3335.3% | -12.6% | -3322.7% |
| ROE | -42.0% | -39.2% | -2.9% |
| ROA | -30.9% | -30.9% | +0.0% |
| Current Ratio | 0.27 | 2.73 | -2.46 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -30.9% | — |
| ✗Flujo de caja operativo positivo | −A$6M | — |
| –Rentabilidad sobre activos al alza | -30.9% | — |
| ✓Caja operativa/activos supera al ROA | -25.7% | ROA -30.9% |
| –Menos deuda a largo plazo | 0.1% | — |
| ✗Mejor liquidez (ratio corriente) | 0.27 | — |
| ✗Sin aumentar el nº de acciones | 9M | — |
| –Margen bruto al alza | 30.3% | — |
| –Rotación de activos al alza | 0.01 | — |
| Calidad del negocio | FY25 |
|---|---|
| ✗Margen FCF > 10 % | -3335.3% |
| ✗ROCE > 10 % | -34.7% |
| ✓Deuda neta/EBITDA < 3x | -0.9x |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 381.4% |
Gelteq Ltd cotiza a 0.45 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud